TANG CAPITAL PARTNERS LP 13D and 13G filings for Jounce Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-11-28 06:00 am Purchase |
2023-11-22 | 13D | Jounce Therapeutics, Inc. JNCE |
TANG CAPITAL PARTNERS LP | 4,033,463 4.800% |
1,007,008 (+33.27%) |
Filing |
| 2023-05-22 09:00 am Purchase |
2023-05-22 | 13D | Jounce Therapeutics, Inc. JNCE |
TANG CAPITAL PARTNERS LP | 3,026,455 3.600% |
3,026,455 (New Position) |
Filing |
| 2023-05-05 4:34 pm Sale |
2023-05-03 | 13D | Jounce Therapeutics, Inc. JNCE |
TANG CAPITAL PARTNERS LP | 10,000 100.000% |
-5,290,087 (-99.81%) |
Filing |
| 2023-04-07 4:00 pm Unchanged |
2023-04-05 | 13D | Jounce Therapeutics, Inc. JNCE |
TANG CAPITAL PARTNERS LP | 5,300,087 10.200% |
0 (Unchanged) |
Filing |
| 2023-03-28 4:00 pm Unchanged |
2023-03-26 | 13D | Jounce Therapeutics, Inc. JNCE |
TANG CAPITAL PARTNERS LP | 5,300,087 10.200% |
0 (Unchanged) |
Filing |
| 2023-03-17 4:00 pm Unchanged |
2023-03-17 | 13D | Jounce Therapeutics, Inc. JNCE |
TANG CAPITAL PARTNERS LP | 5,300,087 10.200% |
0 (Unchanged) |
Filing |
| 2023-03-14 5:00 pm Purchase |
2023-03-14 | 13D | Jounce Therapeutics, Inc. JNCE |
TANG CAPITAL PARTNERS LP | 5,300,087 10.200% |
300,087 (+6.00%) |
Filing |
| 2023-03-06 4:00 pm Purchase |
2023-02-23 | 13G | Jounce Therapeutics, Inc. JNCE |
TANG CAPITAL PARTNERS LP | 5,000,000 9.700% |
5,000,000 (New Position) |
Filing |